Copyright Reports & Markets. All rights reserved.

Global Durvalumab Sales Market Report 2021

Request for Sample of this report
Buy now

1 Durvalumab Market Overview

  • 1.1 Durvalumab Product Scope
  • 1.2 Durvalumab Segment by Type
    • 1.2.1 Global Durvalumab Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 2.4mL Injection
    • 1.2.3 10mL Injection
  • 1.3 Durvalumab Segment by Application
    • 1.3.1 Global Durvalumab Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Locally Advanced Urothelial Carcinoma
    • 1.3.3 Metastatic Urothelial Carcinoma
    • 1.3.4 Other
  • 1.4 Durvalumab Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Durvalumab Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Durvalumab Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Durvalumab Price Trends (2016-2027)

2 Durvalumab Estimates and Forecasts by Region

  • 2.1 Global Durvalumab Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Durvalumab Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Durvalumab Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Durvalumab Revenue Market Share by Region (2016-2021)
  • 2.3 Global Durvalumab Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Durvalumab Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Durvalumab Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Durvalumab Estimates and Projections (2016-2027)
    • 2.4.2 Europe Durvalumab Estimates and Projections (2016-2027)
    • 2.4.3 China Durvalumab Estimates and Projections (2016-2027)
    • 2.4.4 Japan Durvalumab Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Durvalumab Estimates and Projections (2016-2027)
    • 2.4.6 India Durvalumab Estimates and Projections (2016-2027)

3 Global Durvalumab Competition Landscape by Players

  • 3.1 Global Top Durvalumab Players by Sales (2016-2021)
  • 3.2 Global Top Durvalumab Players by Revenue (2016-2021)
  • 3.3 Global Durvalumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Durvalumab as of 2020)
  • 3.4 Global Durvalumab Average Price by Company (2016-2021)
  • 3.5 Manufacturers Durvalumab Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Durvalumab Market Size by Type

  • 4.1 Global Durvalumab Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Durvalumab Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Durvalumab Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Durvalumab Price by Type (2016-2021)
  • 4.2 Global Durvalumab Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Durvalumab Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Durvalumab Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Durvalumab Price Forecast by Type (2022-2027)

5 Global Durvalumab Market Size by Application

  • 5.1 Global Durvalumab Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Durvalumab Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Durvalumab Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Durvalumab Price by Application (2016-2021)
  • 5.2 Global Durvalumab Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Durvalumab Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Durvalumab Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Durvalumab Price Forecast by Application (2022-2027)

6 North America Durvalumab Market Facts & Figures

  • 6.1 North America Durvalumab Sales by Company
    • 6.1.1 North America Durvalumab Sales by Company (2016-2021)
    • 6.1.2 North America Durvalumab Revenue by Company (2016-2021)
  • 6.2 North America Durvalumab Sales Breakdown by Type
    • 6.2.1 North America Durvalumab Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Durvalumab Sales Breakdown by Type (2022-2027)
  • 6.3 North America Durvalumab Sales Breakdown by Application
    • 6.3.1 North America Durvalumab Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Durvalumab Sales Breakdown by Application (2022-2027)

7 Europe Durvalumab Market Facts & Figures

  • 7.1 Europe Durvalumab Sales by Company
    • 7.1.1 Europe Durvalumab Sales by Company (2016-2021)
    • 7.1.2 Europe Durvalumab Revenue by Company (2016-2021)
  • 7.2 Europe Durvalumab Sales Breakdown by Type
    • 7.2.1 Europe Durvalumab Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Durvalumab Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Durvalumab Sales Breakdown by Application
    • 7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)

8 China Durvalumab Market Facts & Figures

  • 8.1 China Durvalumab Sales by Company
    • 8.1.1 China Durvalumab Sales by Company (2016-2021)
    • 8.1.2 China Durvalumab Revenue by Company (2016-2021)
  • 8.2 China Durvalumab Sales Breakdown by Type
    • 8.2.1 China Durvalumab Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Durvalumab Sales Breakdown by Type (2022-2027)
  • 8.3 China Durvalumab Sales Breakdown by Application
    • 8.3.1 China 245 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 245 Sales Breakdown by Application (2022-2027)

9 Japan Durvalumab Market Facts & Figures

  • 9.1 Japan Durvalumab Sales by Company
    • 9.1.1 Japan Durvalumab Sales by Company (2016-2021)
    • 9.1.2 Japan Durvalumab Revenue by Company (2016-2021)
  • 9.2 Japan Durvalumab Sales Breakdown by Type
    • 9.2.1 Japan Durvalumab Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Durvalumab Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Durvalumab Sales Breakdown by Application
    • 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Durvalumab Market Facts & Figures

  • 10.1 Southeast Asia Durvalumab Sales by Company
    • 10.1.1 Southeast Asia Durvalumab Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Durvalumab Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Durvalumab Sales Breakdown by Type
    • 10.2.1 Southeast Asia Durvalumab Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Durvalumab Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Durvalumab Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Durvalumab Market Facts & Figures

  • 11.1 India Durvalumab Sales by Company
    • 11.1.1 India Durvalumab Sales by Company (2016-2021)
    • 11.1.2 India Durvalumab Revenue by Company (2016-2021)
  • 11.2 India Durvalumab Sales Breakdown by Type
    • 11.2.1 India Durvalumab Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Durvalumab Sales Breakdown by Type (2022-2027)
  • 11.3 India Durvalumab Sales Breakdown by Application
    • 11.3.1 India Durvalumab Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Durvalumab Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Durvalumab Business

  • 12.1 Medimmune (AstraZeneca)
    • 12.1.1 Medimmune (AstraZeneca) Corporation Information
    • 12.1.2 Medimmune (AstraZeneca) Business Overview
    • 12.1.3 Medimmune (AstraZeneca) Durvalumab Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Medimmune (AstraZeneca) Durvalumab Products Offered
    • 12.1.5 Medimmune (AstraZeneca) Recent Development

...

    13 Durvalumab Manufacturing Cost Analysis

    • 13.1 Durvalumab Key Raw Materials Analysis
      • 13.1.1 Key Raw Materials
      • 13.1.2 Key Raw Materials Price Trend
      • 13.1.3 Key Suppliers of Raw Materials
    • 13.2 Proportion of Manufacturing Cost Structure
    • 13.3 Manufacturing Process Analysis of Durvalumab
    • 13.4 Durvalumab Industrial Chain Analysis

    14 Marketing Channel, Distributors and Customers

    • 14.1 Marketing Channel
    • 14.2 Durvalumab Distributors List
    • 14.3 Durvalumab Customers

    15 Market Dynamics

    • 15.1 Durvalumab Market Trends
    • 15.2 Durvalumab Drivers
    • 15.3 Durvalumab Market Challenges
    • 15.4 Durvalumab Market Restraints

    16 Research Findings and Conclusion

      17 Appendix

      • 17.1 Research Methodology
        • 17.1.1 Methodology/Research Approach
        • 17.1.2 Data Source
      • 17.2 Author List

      The global Durvalumab market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Durvalumab market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

      Segment by Type
      2.4mL Injection
      10mL Injection

      Segment by Application
      Locally Advanced Urothelial Carcinoma
      Metastatic Urothelial Carcinoma
      Other

      The Durvalumab market is analysed and market size information is provided by regions (countries). Segment by Application, the Durvalumab market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

      By Company
      Medimmune (AstraZeneca)

      Buy now